Page last updated: 2024-11-05

dimethylaminopropionitrile

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Dimethylaminopropionitrile (DMAPN) is a chemical compound that has been extensively studied due to its potential neurotoxicity. It is synthesized through a chemical reaction involving acrylonitrile and dimethylamine. DMAPN is known to induce lesions in the central nervous system, particularly in the cerebellum, leading to ataxia and other neurological impairments. Its effects on the nervous system are attributed to its ability to interfere with the production and function of myelin, the protective sheath around nerve fibers. DMAPN has been used in research to model neurodegenerative diseases like multiple sclerosis and to study the mechanisms of neurotoxicity. The study of DMAPN provides insights into the pathogenesis of neurodegenerative disorders and potentially leads to the development of therapies for these conditions.'

Cross-References

ID SourceID
PubMed CID15615
CHEMBL ID2448942
MeSH IDM0071744

Synonyms (66)

Synonym
unii-4lx1y87099
3-dimethylaminopropannitril
4lx1y87099 ,
ec 217-090-4
LS-12488
1138-25-6
einecs 217-090-4
3-dimethylaminopropiononitrile
dmapn
brn 0773779
ai3-25451
3-dimethylaminopropannitril [czech]
nsc 232
beta-dimethylaminopropionitrile
beta-(n-dimethylamino)propionitrile
3-(dimethylamino)-propanenitrile
hsdb 5029
3-(dimethylamino)propionitrile
nsc-232
3-(dimethylamino)propanenitrile
nsc232
1738-25-6
.beta.-(dimethylamino)propionitrile
3-(n,n-dimethylamino)propionitrile
.beta.-(n-dimethylamino)propionitrile
propionitrile, 3-(dimethylamino)-
dimethylaminopropionitrile
propanenitrile, 3-(dimethylamino)-
wln: nc2n1&1
n,n-(dimethylamino)-3-propionitrile
inchi=1/c5h10n2/c1-7(2)5-3-4-6/h3,5h2,1-2h
3-(dimethylamino)propionitrile, 98%
STK400322
3-dimethylaminopropionitrile
D0662
AKOS000206476
NCGC00249035-01
a-dimethylaminopropionitrile
2-dimethylaminoethyl cyanide
tox21_303032
dtxcid207432
cas-1738-25-6
NCGC00256927-01
dtxsid0027432 ,
tox21_201364
NCGC00258916-01
CHEMBL2448942
BBL013139
FT-0613768
n,n-dimethylamino-3-propionitrile
3-(dimethylamino)-propanenitrile [hsdb]
.beta.-n-dimethylaminopropionitrile
n,n-dimethyl-2-cyanoethylamine
AB00981249-01
3-dimethylaminopropanonitrile
beta-dimethylaminoproprionitrile
mfcd00001957
W-107858
F1791-1558
Z57980324
3-(dimethylamino)propionitrile, technical, >=90% (gc)
3-(dimethylamino)propionitrile, for electrophoresis, >=99.5% (gc)
i(2)-n-dimethylaminopropionitrile
Q223036
D89696
EN300-18465

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Commercially available DMAPN metabolites, administered by gavage, produced toxic effects less adverse than DMAPN."( Studies on the mechanism of urotoxic effects of N,N'-dimethylaminopropionitrile in rats and mice. 1. Biochemical and morphologic characterization of the injury and its relationship to metabolism.
Ahmed, AE; Farooqui, MY; Frankenberg, L; Ghanayem, BI; Mumtaz, MM; Rajaraman, S, 1991
)
0.53

Dosage Studied

ExcerptRelevanceReference
" In order to investigate the mechanism of DMAPN toxicity, we carried out time-course (0-72 h) and dose-response (175-700 mg/kg) studies on the effects of DMAPN in rats and mice."( Studies on the mechanism of urotoxic effects of N,N'-dimethylaminopropionitrile in rats and mice. 1. Biochemical and morphologic characterization of the injury and its relationship to metabolism.
Ahmed, AE; Farooqui, MY; Frankenberg, L; Ghanayem, BI; Mumtaz, MM; Rajaraman, S, 1991
)
0.53
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.00140.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency1.40480.000714.592883.7951AID1259369
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID781327pKa (acid-base dissociation constant) as determined by Morgenthaler ref: ChemMedChem 20072014Pharmaceutical research, Apr, Volume: 31, Issue:4
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (66.67)18.7374
1990's3 (25.00)18.2507
2000's0 (0.00)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.00 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.19 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]